Clear Street’s Oaktree Acquisition Corp III Life Sciences Unit OACCU Stock Holding History

Clear Street’s Portfolio OACCU Stock Details OACCU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$242K	Sell	21,975 -246	-1%	-$2.69K	﹤0.01%	695
2026 Q1	$236K	Hold	22,221	–	–	﹤0.01%	531
2025 Q4	$238K	Buy	22,221 +1,888	+9%	+$20.3K	﹤0.01%	439
2025 Q3	$217K	Sell	20,333 -487	-2%	-$5.2K	﹤0.01%	345
2025 Q2	$221K	Buy	20,820 +19,588	+1,590%	+$206K	﹤0.01%	209
2025 Q1	$12.9K	Buy	+1,232	New	+$12.6K	﹤0.01%	345

Other funds holding OACCU

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Clear Street's OACCU Position: Q2 2026 in Review

Clear Street reduced its Oaktree Acquisition Corp III Life Sciences Unit (OACCU) stake by 1.1% in Q2 2026, selling an estimated $2.69K and leaving 21,975 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #695.

Clear Street first reported a position in OACCU in Q1 2025 and has held it in 6 quarters since. 5 funds tracked by Wall St. Rank hold OACCU as of Q2 2026.

Clear Street held 21,975 shares of Oaktree Acquisition Corp III Life Sciences Unit worth $242K as of Q2 2026.
Clear Street sold 246 Oaktree Acquisition Corp III Life Sciences Unit shares in Q2 2026, an estimated $2.69K.
Oaktree Acquisition Corp III Life Sciences Unit made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #695 holding.
Clear Street first reported a position in Oaktree Acquisition Corp III Life Sciences Unit in Q1 2025 and has held it in 6 quarters since.
5 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Unit as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.